On March 29, 2022, BroadenBio Co., Ltd. (BroadenBio) announced the appointment of Professor Mei Gu and Professor Xianliang Li as the company's clinical medical consultants. "The joining of Professor Gu and Professor Li has comprehensively improved our clinical medical research capabilities, and their rich clinical experience and knowledge will become valuable resources for the company" said Xingmin Zhang, M.D., Ph.D., founder and Chief Executive Officer of BroadenBio.

 

Professor Mei Gu

M.D., Chief Physician, Master Supervisor, Associate Professor, Former Director of Tumor Center of Beijing Tongren Hospital.

 

Expertise & Profession

Participation in the whole process of drug and device research and development

35-Years of clinical study experience

Expert in oncology surgery, hepatobiliary surgery, liver and kidney transplantation, general surgery, comprehensive internal medicine, severe emergency rescue, diagnosis and treatment of difficult and complicated diseases

Honored as the "No. 1 Female Hepatologist in Asia" by her peers

 

Working Experience

Guided clinical studies of dozens of pharmaceutical companies

Responsible for clinical trials of more than ten investigational drugs on clinical trial design, medical monitoring, and clinical project operation

Covering clinic fields of oncology, infections, and cardiovascular diseases

 

Duties & Positions

Member of the Chinese Liver Surgery Group

Member of Beijing Branch of the Chinese Transplantation Society

Member of the Oncology Department of Capital Medical University

Member of the International European Medical Oncology Society

Member of the International Transplantation Society

Member of the Japanese Surgical Society, the Japanese Digestive Surgery Society

Member of the International Surgical Society

Member of the International Society of Transplantation

Expert judges of the National Natural Science Foundation of China

Expert judges of the Capital Development Fund

Expert judges of the Beijing Natural Science Foundation

Expert judges of the Beijing Municipal Science and Technology Commission

 

 

Professor Xianliang Li

M.D., Deputy Chief Physician, Associate Professor, Master Supervisor in Department of Hepatobiliary, Pancreatic and Splenic Surgery, Beijing Chaoyang Hospital.

 

Expertise & Profession

Experienced in the field of hepatobiliary and pancreatic tumors and organ transplantation, especially liver transplantation

Persistent scientific research and exploration in the field of clinical immune transformation

Clinician with profound accumulation in immunology research

 

Education & Working Experience

Graduation from the Department of Clinical Medicine, China Medical University in 1994

Master degree from China Medical University in 1997

Visiting clinical scholar at Queen Mary Hospital of the University of Hong Kong in 2000, funded by the Mrs Ivy Wu Fellowship for PRC Academics

Doctor degree from the University of Hong Kong in 2004, under the supervision of Professor Sheng Tat FAN, academician of the Chinese Academy of Engineering

Postdoctoral fellow at the University of Nantes, France in 2005

Working as an independent research scholar since 2007, leading his own team to conduct in-depth research on the transplantation of immune and regulatory cells

Overseas talent in the Department of Hepatobiliary Surgery of Beijing Chaoyang Hospital since 2010, focusing on tumor immunotherapy, immune tolerance of organ transplantation, and green tumor treatment mode exploration

 

Publications & Awards

Research Fellowship of the World Society for Organ Transplantation at the World Organ Transplant Congress, Boston, 2006

Senior Research Scholar Grant of the European Society for Organ Transplantation, 2008

Invited presentation and Executive Chair of the Clinical Immune Tolerance Research Branch at the World Congress on Organ Transplantation, Sydney, 2008

National Nature Foundation for six consecutive years

30+ Domestic and overseas research projects, grants of more than 10 million (CNY) in total

80+ Publications of journal articles, participated monographs editing and international conference papers, including 25 journal and conference publications indexed by SCI, with a cumulative impact factor of 120+ and a total of 350 citations

Featured in the “Famous Doctors in Famous Hospitals” column of the Scientific Chinese magazine in Jan. 2014

Annual Person in the field of medicine and health, Scientific Chinese magazine, 2014

Annual Good Doctor of China, 2017

Leading talent of "E-Kirin" new innovation project of Beijing Economic-Technology Development Area, 2018

 

Duties & Positions

Guest reviewer of Intensive Care Medicine, International Journal of Biomedical Science, Hepatobiliary & Pancreatic Diseases International, and Journal of Asthma and Allergy

Editorial board member of The Open Surgery Journal, International Journal of Clinical Medicine, American Journal of Immunology, Liver Tumor, Chinese Journal of Cell and Stem Cell, and Chinese Journal of Diagnostics (electronic edition)

Member of the Basic Research Group of the 17th Organ Transplantation Society of Chinese Medical Association

Member of the Organ Transplantation Immunology Group of Organ Transplantation Branch of Chinese Medical Doctor Association

Member of the Translational Medicine and Experimental Surgery Group of Chinese Medical Association

Member of the Liver Transplantation Branch of China Medical Care International Promotion Association

Member of the Hepatobiliary Disease Prevention Branch of the China Association for the International Promotion of Healthcare

Member of the Hepatobiliary and Pancreatic Surgery Professional Committee of the Cross-Straits Medical and Health Exchange Association

Deputy Head of the Metabolic Management Group of Liver Transplantation Branch of China Medical Care International Promotion Association

Executive director of the Precision Medicine and Tumor Rehabilitation Professional Committee of China Rehabilitation Technology Transformation and Development Promotion Association

Member of the Standing Committee of the Biodiagnostic Technology Branch of the China Medical Biotechnology Association, and Leader of the Immunological Assessment and Immunotherapy Group

Member of the Standing Committee of the National (Zhongguancun) Minimally invasive cancer treatment industry technology innovation strategic alliance General professional Committee

Member of the World Organ Transplant Association

Member of the European Organ Transplant Society